This is a sign of the relative quality of management between MSB and Biogen. One fails at everything it touches and the other gets the job done.
All I am hearing is sour grapes .... 'fails at everything it touches' .... come on !
Even @Pledge will say MSB are great at Capital Raising so hardly 'failing at everything' lol
Alzheimer drug approved, page-51
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $1.304B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.17 | $1.13 | $3.335M | 2.908M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7094 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 54456 | 2 |
View Market Depth
| Last trade - 15.59pm 22/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |